1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Navigating Through API Industry Global And Indian Scenario

Admin
7 February 2024

Introduction:

Active Pharmaceutical Ingredients are the biologically active components of pharmaceutical drugs, providing therapeutic effects. These ingredients go through extensive API manufacturing companies’ research, development and evaluation before getting used into the formulations. To ensure the efficacy and safety of pharmaceutical products, APIs can be synthetic or taken from natural sources, and their quality is of utmost importance.

This blog aims to provide a detailed overview of APIs, including definition, sources, types, market dynamics, growth rates, main players and their role in this growing sector through the use of databases like Chemxpert Database.

Source:

API can be derived from a variety of sources and, before being placed on the market for use, they are generally made into an ultimate dosage form such as tablets or capsules. Some sources includes:

Synthetic Chemistry: A number of APIs are synthesized by chemicals, which allows their composition and structure to be precisely controlled.
Biotechnological Processes: Through genetic engineering and fermentation, advances in biotechnology have made it possible to produce APIs.
Natural Sources: Natural sources such as plants, animals or microorganisms are used to extract some of the APIs.

Types:

The synthetic and natural APIs are the major types of active pharmaceutical ingredients. Depending on the way in which they are manufactured, synthetic APIs can also be distinguished as new and generic forms. They're at the heart of all pharmaceutical products in the market.

Market Size and Growth Rate:

Over the analysis period 2022 to 2030, the worldwide market for API is estimated to grow at a compounded annual growth rate of 6.3% CAGR. (Courtesy: Research and markets)

In recent years, there has been substantial growth in the world API market. This growth is being driven by factors such as:

Increased Demand: The demand for a wide range of pharmaceutical products is driven by an increasing global need for healthcare.
Expanding Aging Population: A wider range of treatment options is needed for an ageing population around the world.
Advancements in Biotechnology: The scope of API production has been broadened by biotechnological innovations.
Growing Prevalence of Chronic Diseases: The demand for Innovative APIs is driven by conditions such as diabetes, heart disease and cancer.

Importers/Suppliers:

A network of importers, exporters and suppliers plays an important role in the API industry. The key players in the global API market are as follows:

China: One of the world's largest suppliers of APIs, using its manufacturing capabilities and cost effectiveness.
India: India is a major exporter to different markets, known for its high presence in general API.
United States and Europe: Importers of APIs who use global suppliers in order to meet the demand for pharmaceutical manufacturing.

Top Companies:

The API market is dominated by a number of API manufacturing companies, such as:

Teva Pharmaceutical Industries Ltd. (Israel): The company is known for its broad portfolio of Generic APIs.
Dr. Reddy's Laboratories Ltd. (India): A significant player in the Indian pharmaceutical sector, specializing in APIs and formulations.
Pfizer Inc. (United States): A global pharmaceutical company with a strong presence in the area of API production.

Other major companies are: Merck KGaA, BASF SE, and Viatris Inc., etc.

Indian API Landscape:

The Indian market for API is projected to grow from USD 13.64 billion in 2024 to USD 20.32 billion in 2029 at a compound annual growth rate of 8.31% over the time period between 2020 and 2030. (Courtesy: Mordor Intelligence)

Role of Databases like Chemxpert Database:

Chemical databases such as Chemxpert, which has become top api pharma database company in India play an important role within this dynamic and rapidly developing API sector, which includes:-

Data Centralization: Chemxpert database provides the complete information on APIs, making it easier to get the data that is essential for research and development.
Market Insights: Databases helps users to gain important insight for market trends, competitors' activities, and regulatory variables.
Supplier Information: It helps companies for finding right supplier, the Chemxpert database offers precise information on API suppliers.
Regulatory Compliance: Reach to regulatory data ensures that companies stay compliant with continuously changing standards and requirements.

Conclusion:

For the development and manufacture of medicinal products, the Pharma industry relies heavily on the API sector. Stakeholders must understand the complexities of APIs, comprehend market dynamics and realize how important databases such as Chemxpert are for navigating this complex environment. Given the continuous evolution of these sectors, success in this crucial global healthcare sector depends on a high degree of vigilance towards emerging trends and technologies.